Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inventiva (IVA) Cash & Equivalents (2018 - 2025)

Inventiva has reported Cash & Equivalents over the past 8 years, most recently at $115.6 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 11.98% year-over-year to $115.6 million; the TTM value through Dec 2025 reached $115.6 million, up 11.98%, while the annual FY2025 figure was $115.6 million, 11.98% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $115.6 million at Inventiva, up from $138185.1 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $130.0 million in Q1 2021 and troughed at $138185.1 in Q2 2025.
  • A 5-year average of $75.2 million and a median of $92.4 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 967.79% in 2024 and later tumbled 99.52% in 2025.
  • Year by year, Cash & Equivalents stood at $99.0 million in 2021, then decreased by 10.63% to $88.5 million in 2022, then plummeted by 89.08% to $9.7 million in 2023, then skyrocketed by 967.79% to $103.2 million in 2024, then rose by 11.98% to $115.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for IVA at $115.6 million in Q4 2025, $138185.1 in Q2 2025, and $103.2 million in Q4 2024.